Atossa Therapeutics Inc (ATOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ATOS | TMO | ISRG | EW | DXCM |
| Company | Atossa Therapeutics Inc | Thermo Fisher Scientific Inc | Intuitive Surg Inc | Edwards Lifesciences Corp | Dexcom Inc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NYSE | NASDAQ |
| Open | 1.5400 | 579.48 | 373.64 | 84.90 | 127.03 |
| High | 1.5700 | 579.79 | 377.88 | 85.44 | 127.88 |
| Low | 1.4900 | 565.49 | 367.39 | 83.81 | 124.61 |
| Last | 1.5200 | 571.25 | 377.65 | 85.06 | 126.65 |
| Change | -0.0100 | -3.74 | +5.95 | +0.76 | +0.77 |
| % Change | -0.65% | -0.65% | +1.60% | +0.90% | +0.61% |
| Volume | 1,191,786 | 1,351,538 | 1,001,453 | 1,936,563 | 2,297,085 |
| 20-Day Average Volume | 2,256,824 | 1,408,847 | 1,481,853 | 3,001,248 | 2,993,144 |
| Previous Close | 1.5300 | 574.99 | 371.70 | 84.30 | 125.88 |
| Industry | Medical Instruments | Medical Instruments | Medical Instruments | Medical Instruments | Medical Instruments |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.5790 | 567.22 | 378.22 | 88.40 | 133.84 |
| 20-Day Raw Stochastic | 26.17% | 69.02% | 45.71% | 16.23% | 18.90% |
| 20-Day Relative Strength | 50.79% | 51.13% | 48.66% | 41.39% | 44.31% |
| Weighted Alpha | +87.03 | +8.42 | +25.94 | +1.16 | +9.72 |
| Today's Opinion | 72% Buy | 56% Buy | 40% Buy | 40% Buy | 40% Buy |
| Previous Opinion | 72% Buy | 72% Buy | 40% Buy | 40% Buy | 40% Buy |
| Last Month's Opinion | 100% Buy | 80% Buy | 64% Buy | 88% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | unch since 04/25/24 | -0.08% since 04/25/24 | +1.21% since 04/25/24 | -3.35% since 04/25/24 | -8.23% since 04/25/24 |
| Low | 1.4700 on 05/01/24 | 565.49 on 05/02/24 | 367.39 on 05/02/24 | 83.50 on 05/01/24 | 123.07 on 04/29/24 |
| High | 1.5950 on 04/26/24 | 581.90 on 05/01/24 | 379.50 on 05/01/24 | 88.38 on 04/26/24 | 138.80 on 04/26/24 |
| 1-Month | |||||
| %Chg | -17.39% since 04/02/24 | -0.05% since 04/02/24 | -1.23% since 04/02/24 | -9.81% since 04/02/24 | -7.32% since 04/02/24 |
| Low | 1.2400 on 04/18/24 | 529.64 on 04/18/24 | 364.17 on 04/19/24 | 83.50 on 05/01/24 | 123.07 on 04/29/24 |
| High | 2.3100 on 04/05/24 | 589.93 on 04/09/24 | 393.66 on 04/05/24 | 95.07 on 04/03/24 | 141.99 on 04/09/24 |
| 3-Month | |||||
| %Chg | +78.19% since 02/02/24 | +3.52% since 02/02/24 | -1.59% since 02/02/24 | -1.20% since 02/02/24 | +4.70% since 02/02/24 |
| Low | 0.8279 on 02/05/24 | 529.64 on 04/18/24 | 364.17 on 04/19/24 | 82.53 on 02/07/24 | 113.05 on 02/28/24 |
| High | 2.3100 on 04/05/24 | 603.82 on 03/08/24 | 403.76 on 03/27/24 | 96.12 on 03/28/24 | 142.00 on 03/26/24 |
| 6-Month | |||||
| %Chg | +117.77% since 11/02/23 | +27.63% since 11/02/23 | +35.90% since 11/02/23 | +29.80% since 11/02/23 | +35.21% since 11/02/23 |
| Low | 0.6200 on 11/13/23 | 437.26 on 11/10/23 | 269.49 on 11/10/23 | 63.88 on 11/10/23 | 91.49 on 11/08/23 |
| High | 2.3100 on 04/05/24 | 603.82 on 03/08/24 | 403.76 on 03/27/24 | 96.12 on 03/28/24 | 142.00 on 03/26/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 191,715 | 219,481,728 | 131,844,224 | 50,799,180 | 50,060,460 |
| Shares Outstanding, K | 125,304 | 381,714 | 354,706 | 602,600 | 397,684 |
| Annual Sales | 0 | 42,857,000,000 | 7,124,100,000 | 6,004,800,000 | 3,622,300,000 |
| Annual Net Income | -30,090,000 | 5,995,000,000 | 1,798,000,000 | 1,402,400,000 | 541,500,000 |
| Last Quarter Sales | 0 | 10,345,000,000 | 1,890,600,000 | 1,598,200,000 | 921,000,000 |
| Last Quarter Net Income | -7,750,000 | 1,327,000,000 | 544,900,000 | 351,900,000 | 146,400,000 |
| 60-Month Beta | 1.27 | 0.80 | 1.39 | 1.10 | 1.23 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.06 on 04/01/24 | 5.11 on 04/24/24 | 1.50 on 04/18/24 | 0.66 on 04/25/24 | 0.32 on 04/25/24 |
| Latest Earnings Date | 05/20/24 | 04/24/24 | 04/18/24 | 04/25/24 | 04/25/24 |
| Most Recent Dividend | N/A | 0.390 on 03/14/24 | N/A | N/A | N/A |
| Next Ex-Dividends Date | N/A | 03/14/24 | N/A | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 26.31 | 79.19 | 33.20 | 76.74 |